Pain Management Flashcards
COX enzyme differences
COX 1 has tighter active site shape
COX 2 could be specifically targeted by using larger drugs
COX enzyme function
Convert arachidonic acid to prostaglandins G and H
COX 1 is generally cytoprotective
COX 2 is induced by injurious stimuli, may be constitutively expressed in brain and kidney
Prostaglandin role in pain
Mainly PGE
EP1 receptor - increased bradykinin sensitivity, K+ channel inhibition, increased Na+ channel sensitivity
EP2 receptor - decreased glycine receptor affinity
EP3 - pyrexia
NSAIDs therapeutic effects
Via COX 2 inhibition
Prevents arachidonic acid conversion to PGs
Analgesia
Anti inflammatory
NSAID pharmacokinetics
Oral or topically if soft tissue injury
Heavily protein bound (90-99%)
Linear pharmacokinetics within therapeutic dose range
T 1/2 - two groups - more than 10 hours (naproxen) or less than 6 (ibuprofen)
NSAID DDIs
If two NSAIDs unknowingly given together
Protein displacement-sulfonylureas, warfarin, methotrexate
NSAIDs ADRs
Hypersensitivity - aspirin induced asthma, skin rashes. Don’t give in asthma because leukotrienes
Reye’s syndrome - rare, serious - brain/liver injury
Stevens-Johnson syndrome - rash of skin and mucous membranes
Increased clotting time
Renal (reduced blood flow - PGE2 and I2 maintain renal blood flow)
GI - peptic ulcers
Ibuprofen
NSAID
Aspirin
NSAID
Irreversible COX inhibition (acetylation)
Antiplatelet
Anti GI and breast cancer?
Rofecoxib
Celecoxib
COX 2 inhibitors
COX 2 inhibitors
Should have fewer ADRs
Short term use only
Paracetamol mechanism
Unknown - weak COX inhibitor
Perhaps on COX 3 isoform in CNS
Paracetamol pharmacokinetics
First order in healthy patient
T1/2 2-4 hrs
Caution if poor hepatic function
Paracetamol toxicology
NAPQI made - depletes glutathione - hepatocyte death Also renal failure Give N acetyl cysteine in first 36 hrs Methionine if can't be given promptly Activated charcoal in first 4 hrs
Endogenous opioids
Endomorphins 1 and 2 (mu receptor)
Enkephalins - metenkephalin, leuenkephalin
Endorphins (from POMC)
Newly discovered - nociceptin, nocistatin
Opioid receptors
Mu (MOP) in CNS (supra spinal) - analgesic via increased K+ efflux
Delta (DOP) widely distributed in CNS. Bind enkephalins, work via decreased cAMP synthesis
Kappa (KOP) in spinal cord - analgesia via calcium channel block
Morphine
Opioid receptor agonist
Gold standard opioid analgesic
Morphine structure
Has two hydroxyl groups - not lipid soluble
Active site is amine group
Morphine metabolism
Glucuronidated to morphine 6 glucuronide or morphine 3 glucuronide
Can be screened for in urine
Morphine oral bioavailability
25%
Morphine uses
Terminal illness analgesia
Diarrhoea
Diamorphine
Heroin
Diacetylmorphine
Diamorphine structure
OH groups replaced by acetyl groups
Lipid soluble
Can cross BBB
Diamorphine half life
Short as ester bonds easily broken down by pseudocholinesterases
Broken down to morphine
Diamorphine uses
Analgesia terminal illness
Epidural analgesia NOT LICENSED.
Methodone
Opioid used for maintenance in dependance.
Tramadol
Analgesic
Has 5-HT and NA effects
Tapentadol
Specific mu agonist
NA reuptake inhibitor
Analgesic
Codeine
Oral
Mild analgesic
Metabolised to morphine by CYP2D6
Does not work in people with altered enzyme
Synthetic opioids
Very potent
Anaesthetics
Fentanyl
Synthetic opioid
Alfenatil
Synthetic opioid
Remifenatil
Synthetic opioid
Pethidine
Opioid
Analgesia in labour
But relaxes uterus and can cross placenta causing respiratory depression in the neonate
IM
Cannot give repeated doses as norpethidine (metabolite) causes convulsions
Opioid agonist/antagonist
Action depends on receptor type
All analgesic
Pentazocine
Opioid agonist/antagonist
Causes dysphoria
Nalbuphine
Opioid agonist/antagonist
Butaphanol.
Opioid agonist/antagonist
Buprenorphine
Opioid agonist/antagonist
Meptazinol
Opioid agonist/antagonist
Opioid antagonists
Used in opioid toxicity, respiratory depression and dependence treatment
Mu antagonists - naloxone T1/2 1-1.5 hrs. High affinity so can compete effectively.
Naltrexone T1/2 4 hrs
Opioid ADRs
GI- vomiting, constipation Drowsiness Miosis Respiratory depression Hypotension Dependence, tolerance All mu receptor K receptor - dysphoria